ClinicalTrials.gg
Status unknownNCT01922453RITMOUpdated Aug 14, 2013

Music and Sounds for ECV

An interventional study of Music and Sound in Breech Presentation and Vertex Presentation, sponsored by Hadassah Medical Organization. Status unknown at 1 site in Israel. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-08-14.

Sponsored by Hadassah Medical Organization · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2013), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This international study is looking to see if the addition of music and sound on the maternal abdomen encourages fetal position change from breech to vertex in near term women.

02

Conditions studied

  • Breech Presentation
  • Vertex Presentation

Browse trials for

Keywords

  • breech presentation
  • vertex presentation
03

In context

Breech Presentation

41 studies on the registry are indexed under Breech Presentation; 10 are open to participants now.

This study's planned enrollment of 60 is below the median of 119 across 31 interventional studies indexed under Breech Presentation.

Browse Breech Presentation studies →

Lead sponsor

Hadassah Medical Organization is the lead sponsor of 675 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • pregnant women near term with breech presentation.

Exclusion criteria

Exclusion Criteria:

  • women with a for vaginal birth
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Music and Sound

    Music and Sound applied to maternal abdomen through a special device for pregnant women.

    Other: Music and Sound

  • No intervention
    no music and sound

Interventions

  • OtherMusic and Sound
06

What researchers measure

Primary outcomes

  1. vertex position

    Time frame: 3 days post intervention

07

Study locations

1 site
  • Hadassah Medical Organization
    Jerusalem, Israel
    • Hadas Lemberg, MD · Contactlhadas@hadassah.org.il · 00 972 2 6777572
    • Hagit Daum, MD · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2013, a primary completion of Sep 2014 and a completion of Sep 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2013
First posted
Aug 14, 2013
Start
Sep 2013
Primary completionEst.
Sep 2014
CompletionEst.
Sep 2014
Last update
Aug 14, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 14, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01922453
Responsible party
Sponsor
First posted
Aug 14, 2013
Start date
Sep 2013
Primary completion
Sep 2014 (estimated)
Completion
Sep 2014 (estimated)
Last update
Aug 14, 2013

Study contacts

Hagit Daum, MD
Contact
dhagit@hadassah.org.il
00 972 53 8246261
Hagit Daum, MD
principal investigator · Hadassah Medical Organization

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion